divestment
![glenmark nirma api deal valuation, glenmark life sciences nirma acquisition, glenmark debt problem solved by api sale, nirma expands pharma portfolio with glenmark api, glenmark api deal impact on shareholders, glenmark api deal open offer details, glenmark api deal future strategy](https://pharmtales.com/wp-content/uploads/2023/09/Glenmark-sells-API-business-to-Nirma-for-681M-wipes-out-debt.jpg)
Glenmark sells API business to Nirma for $681M, wipes out debt
Anika Sharma
Glenmark Pharmaceuticals has successfully resolved its long-standing debt issue by divesting 75% of its active pharmaceutical ingredient (API) business. The ...